Regulation of Kappa opioid receptor-mediated signaling and peripheral analgesia
Kappa 阿片受体介导的信号传导和外周镇痛的调节
基本信息
- 批准号:8972021
- 负责人:
- 金额:$ 27.95万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-01-15 至 2017-11-30
- 项目状态:已结题
- 来源:
- 关键词:Absence of pain sensationAcuteAdenylate CyclaseAdultAdverse effectsAffectAfferent NeuronsAgonistAmericanAnalgesicsAttentionBehavioralBehavioral ModelClinical ResearchCoronary heart diseaseDataDevelopmentDiabetes MellitusDoseDose-LimitingFoundationsGoalsHealthHeart DiseasesHumanInflammationInflammation MediatorsInvestigationLeadLegalLigandsMAPK8 geneMalignant NeoplasmsMeasuresMediatingMedicalMitogen-Activated Protein KinasesMorphineN-terminalNeuronsNociceptionNociceptorsOpioidOpioid AnalgesicsOpioid ReceptorPainPain managementPatientsPeripheralPharmaceutical PreparationsPharmacotherapyPhasePhosphotransferasesPrimary Cell CulturesQuality of lifeRattusReceptor SignalingRegulationResearchRoleShapesStimulusSystemTranslatingTreatment EfficacyUnited StatesVentilatory DepressionWorkaddictionbehavioral studycostdesensitizationimprovedin vivoinflammatory paininhibitor/antagonistnovelnovel strategiesreceptor functionreceptor-mediated signalingresearch studyresponsesalvinorin Asocial
项目摘要
DESCRIPTION (provided by applicant): Pain affects more Americans than does diabetes, heart disease and cancer combined. Opioids are a key drug class for pain treatment; however, there are significant drawbacks (e.g. CNS adverse effects, social and legal issues) that limit their use for effective management of pain. Consequently, development of novel approaches for improved pain control is a critically important research objective. To eliminate adverse CNS-derived effects, attention has turned to targeting peripherally located opioid receptors expressed on the pain-sensing neurons themselves. Importantly, the regulatory mechanisms of opioid receptor systems in peripheral sensory neurons are unique, and results obtained from studies in other systems (CNS, heterologous expression systems, etc.) do not always translate to peripheral sensory neurons. Thus, to understand opioid receptor function in peripheral sensory neurons, experiments must be done with peripheral sensory neurons. The goal of this project is to study the regulation of kappa opioid receptor (KOR) signaling systems in peripheral sensory neurons, using primary cultures of adult rat sensory neurons and a behavioral model of nociception. Our specific aims are 1) To delineate the role of ERK in regulation of KOR function in peripheral sensory neurons; 2) To delineate the role of JNK in regulation of KOR function in peripheral sensory neurons; and 3) To delineate the role of acute desensitization in regulating KOR agonist efficacy in peripheral sensory neurons. Our overall goal is to increase the reliability and therapeutic efficacy of peripherally-restricted kappa opioid analgesic drugs. By understanding the cellular mechanisms that are involved in regulating the responsiveness of kappa opioid receptor systems on peripheral sensory neurons, improved approaches to treat pain can be developed that have improved therapeutic efficacy and are devoid of debilitating CNS-mediated adverse effects. The combination of rigorous mechanistic studies using primary sensory neurons in culture with the translational value of behavioral studies provides a powerful approach to understanding the regulation of kappa opioid receptor agonist efficacy in a physiologically relevant system and may lead to new approaches for improved pharmacotherapy for pain.
描述(由申请人提供):疼痛对美国人的影响超过了糖尿病、心脏病和癌症的总和。阿片类药物是治疗疼痛的关键药物;然而,有明显的缺点(例如中枢神经系统的不良反应,社会和法律问题)限制了它们用于有效治疗疼痛的使用。因此,开发改善疼痛控制的新方法是一个至关重要的研究目标。为了消除中枢神经系统衍生的不良影响,人们的注意力已经转向靶向外周位于痛觉神经元上表达的阿片受体。重要的是,外周感觉神经元中阿片受体系统的调节机制是独特的,其他系统(中枢神经系统、异源表达系统等)的研究结果并不总是适用于外周感觉神经元。因此,要了解阿片受体在外周感觉神经元中的作用,必须对外周感觉神经元进行实验。本项目的目的是研究kappa阿片受体(KOR)信号系统在外周感觉神经元中的调控,利用成年大鼠感觉神经元的原代培养和伤害感觉的行为模型。我们的具体目标是:1)描述ERK在调节周围感觉神经元KOR功能中的作用;2)研究JNK对周围感觉神经元KOR功能的调控作用;3)描述急性脱敏在调节KOR激动剂在外周感觉神经元中的作用。我们的总体目标是提高外周限制性卡帕阿片类镇痛药物的可靠性和治疗效果。通过了解参与调节kappa阿片受体系统对周围感觉神经元的反应性的细胞机制,可以开发改进的治疗疼痛的方法,提高治疗效果,并且没有衰弱的中枢神经系统介导的不良反应。利用培养的初级感觉神经元进行严格的机制研究与行为研究的转化价值相结合,为理解kappa阿片受体激动剂在生理相关系统中的功效调节提供了强有力的途径,并可能为改进疼痛药物治疗提供新方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WILLIAM P CLARKE其他文献
WILLIAM P CLARKE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WILLIAM P CLARKE', 18)}}的其他基金
Identification of allosteric molecules for DOR-KOR heteromer-mediated peripheral analgesia
DOR-KOR 异聚体介导的外周镇痛变构分子的鉴定
- 批准号:
10608439 - 财政年份:2023
- 资助金额:
$ 27.95万 - 项目类别:
Development of a phenotypic screening assay for novel compounds that inhibit peripheral pain-sensing neurons
开发抑制外周痛觉神经元的新型化合物的表型筛选试验
- 批准号:
10650640 - 财政年份:2023
- 资助金额:
$ 27.95万 - 项目类别:
Pharmacological and behavioral effects of MCAM: a long-acting, μ opioid receptor antagonist for treatment of opioid overdose and opioid abuse disorder
MCAM 的药理和行为影响:一种长效、μ阿片受体拮抗剂,用于治疗阿片类药物过量和阿片类药物滥用障碍
- 批准号:
10091419 - 财政年份:2019
- 资助金额:
$ 27.95万 - 项目类别:
Pharmacological and behavioral effects of MCAM: a long-acting, μ opioid receptor antagonist for treatment of opioid overdose and opioid abuse disorder
MCAM 的药理和行为影响:一种长效、μ阿片受体拮抗剂,用于治疗阿片类药物过量和阿片类药物滥用障碍
- 批准号:
9923616 - 财政年份:2019
- 资助金额:
$ 27.95万 - 项目类别:
KOR agonist functional selectivity in peripheral sensory neurons
KOR 激动剂在外周感觉神经元中的功能选择性
- 批准号:
9301785 - 财政年份:2015
- 资助金额:
$ 27.95万 - 项目类别:
Regulation of Kappa opioid receptor-mediated signaling and peripheral analgesia
Kappa 阿片受体介导的信号传导和外周镇痛的调节
- 批准号:
8794814 - 财政年份:2014
- 资助金额:
$ 27.95万 - 项目类别:
Regulation of Kappa opioid receptor-mediated signaling and peripheral analgesia
Kappa 阿片受体介导的信号传导和外周镇痛的调节
- 批准号:
8632174 - 财政年份:2014
- 资助金额:
$ 27.95万 - 项目类别:
Regulation of DOR-KOR heteromer formation in pain-sensing neurons
痛觉神经元中 DOR-KOR 异聚体形成的调节
- 批准号:
8824055 - 财政年份:2014
- 资助金额:
$ 27.95万 - 项目类别:
Regulation of opioid receptor function in trigeminal ganglion
三叉神经节阿片受体功能的调节
- 批准号:
8094524 - 财政年份:2009
- 资助金额:
$ 27.95万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 27.95万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 27.95万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 27.95万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 27.95万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 27.95万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 27.95万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 27.95万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 27.95万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 27.95万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 27.95万 - 项目类别:
Operating Grants